- Home
- NXN vs FBIO Comparison
NXN vs FBIO Comparison
Compare NXN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- FBIO
- Stock Information
- Founded
- NXN 1992
- FBIO 2006
- Country
- NXN United States
- FBIO United States
- Employees
- NXN N/A
- FBIO N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NXN Finance
- FBIO Health Care
- Exchange
- NXN Nasdaq
- FBIO Nasdaq
- Market Cap
- NXN 45.4M
- FBIO 53.5M
- IPO Year
- NXN N/A
- FBIO N/A
- Fundamental
- Price
- NXN $11.73
- FBIO $2.58
- Analyst Decision
- NXN
- FBIO Strong Buy
- Analyst Count
- NXN 0
- FBIO 2
- Target Price
- NXN N/A
- FBIO $16.50
- AVG Volume (30 Days)
- NXN 9.7K
- FBIO 440.9K
- Earning Date
- NXN 01-01-0001
- FBIO 08-14-2025
- Dividend Yield
- NXN 4.23%
- FBIO N/A
- EPS Growth
- NXN N/A
- FBIO N/A
- EPS
- NXN 0.24
- FBIO N/A
- Revenue
- NXN N/A
- FBIO $59,301,000.00
- Revenue This Year
- NXN N/A
- FBIO $51.59
- Revenue Next Year
- NXN N/A
- FBIO $44.74
- P/E Ratio
- NXN $48.42
- FBIO N/A
- Revenue Growth
- NXN N/A
- FBIO N/A
- 52 Week Low
- NXN $10.64
- FBIO $1.33
- 52 Week High
- NXN $12.45
- FBIO $2.67
- Technical
- Relative Strength Index (RSI)
- NXN 58.16
- FBIO 74.03
- Support Level
- NXN $11.67
- FBIO $2.30
- Resistance Level
- NXN $11.78
- FBIO $2.49
- Average True Range (ATR)
- NXN 0.08
- FBIO 0.16
- MACD
- NXN 0.00
- FBIO 0.05
- Stochastic Oscillator
- NXN 74.07
- FBIO 88.31
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.